Paperpal Prime Logo

Annals of Clinical Microbiology and Antimicrobials : Impact Factor & More

eISSN: 1476-0711pISSN: 1476-0711
JournalOpen Access

Key Metrics

CiteScore
6
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Infectious Diseases
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Annals of Clinical Microbiology and Antimicrobials

Annals of Clinical Microbiology and Antimicrobials Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Springer Nature
Language English
Frequency Continuous publication
Article Processing ChargesGBP 1890 | USD 2790
Publication Time11
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Annals of Clinical Microbiology and Antimicrobials ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Annals of Clinical Microbiology and Antimicrobials

Clinical features of nontuberculous mycobacteria and diagnosis with nanopore targeted sequencing: a retrospective cohort study.
  • 16 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Specimen-specific distribution of multidrug-resistant organisms and its association with glycemic control in adults with diabetes: a retrospective clinical microbiology study in southern Taiwan.
  • 12 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Incidence, mortality and risk factors of invasive pulmonary aspergillosis in critically ill patients during the COVID-19 era: a global systematic review and meta-analysis.
  • 10 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Effectiveness of cefazolin versus anti-staphylococcal β-lactam for treating methicillin-susceptible Staphylococcus aureus pneumonia in critically ill patients admitted to intensive care units: a multicenter cohort study.
  • 8 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Rare emergence of delamanid resistance in multidrug-/rifampicin-resistant tuberculosis patients receiving delamanid-containing regimens: a prospective multicentric study in China
  • 2 Jul 2026
  • Annals of Clinical Microbiology and Antimicrobials
Convergent evolution of ST2 and ST164 mediates dissemination of the blaNDM-1/blaOXA-23 profile in Acinetobacter baumannii.
  • 22 Jun 2026
  • Annals of clinical microbiology and antimicrobials
Clinical features of nontuberculous mycobacteria and diagnosis with nanopore targeted sequencing: a retrospective cohort study.
  • 16 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Specimen-specific distribution of multidrug-resistant organisms and its association with glycemic control in adults with diabetes: a retrospective clinical microbiology study in southern Taiwan.
  • 12 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Incidence, mortality and risk factors of invasive pulmonary aspergillosis in critically ill patients during the COVID-19 era: a global systematic review and meta-analysis.
  • 10 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Effectiveness of cefazolin versus anti-staphylococcal β-lactam for treating methicillin-susceptible Staphylococcus aureus pneumonia in critically ill patients admitted to intensive care units: a multicenter cohort study.
  • 8 Jul 2026
  • Annals of clinical microbiology and antimicrobials
Rare emergence of delamanid resistance in multidrug-/rifampicin-resistant tuberculosis patients receiving delamanid-containing regimens: a prospective multicentric study in China
  • 2 Jul 2026
  • Annals of Clinical Microbiology and Antimicrobials
Convergent evolution of ST2 and ST164 mediates dissemination of the blaNDM-1/blaOXA-23 profile in Acinetobacter baumannii.
  • 22 Jun 2026
  • Annals of clinical microbiology and antimicrobials

FAQs on Annals of Clinical Microbiology and Antimicrobials